Navigation Links
Australia's Leading Juice Company Launches Juice Blend with Martek's life'sDHA(TM)
Date:3/13/2008

COLUMBIA, Md., March 13 /PRNewswire-FirstCall/ -- Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA-omega 3 for brain, eye and heart health, is available in the new Berri Australian Fresh Omega-3 for Heart & Mind juice-blend from National Foods, Australia's No. 1 juice company. National Foods is the largest citrus and fruit processor in Australia, packaging approximately 50 percent of all fruit juice beverages sold in the country. Sold in major retailers across Australia and available in extra pulpy orange flavor with DHA omega-3 for heart and mind, Berri Australian Fresh Omega-3 for Heart & Mind juice-blend provides 50mg per serving of life'sDHA.

"Berri Australian Fresh Omega-3 for Heart & Mind juice-blend marks our second product with National Foods, joining Pura(R) Kids with life'sDHA," said Joe Buron, vice president of marketing and sales for Martek. "We're pleased to be working with one of Australia's largest food companies through their Pura and Berri brands to offer a safe, contaminant-free alternative for Australian consumers to get the important health benefits of DHA."

DHA (docosahexaenoic acid) omega-3 is a long-chain omega-3 fatty acid that serves as a primary building block for the brain and the eyes and supports brain, eye and cardiovascular health throughout life. There is a large and growing body of scientific evidence demonstrating that people of all ages, from infants to aging adults, benefit from an adequate supply of DHA omega-3 in their diets. Several recent scientific reviews have noted the importance of DHA omega-3 in proper brain and eye development and function, and there are clinical studies underway to evaluate its role in decreasing the prevalence of certain neurological disorders.

Fish are often thought to be the only source of DHA omega-3. However, life'sDHA offers a safe, vegetarian form of DHA that contains no oceanic pollutants and toxins. Fish are rich sources of DHA because they eat microalgae; life'sDHA is derived from microalgae and produced in an FDA- inspected facility from start to finish using a sustainable source that does not deplete ocean resources. life'sDHA is found in numerous foods, beverages and supplements for people of all ages. It is also the only source of DHA used in U.S. infant formula and is available in more than 90 percent of the formulas on the U.S. market.

In Australia, Martek is represented by distributor VILCO PTY LTD, Australia, to maximize the availability of life'sDHA in food and beverages.

National Foods is a wholly owned subsidiary of Kirin Holdings Company, Limited -- Incorporated in Japan. It is one of Australia's largest food companies, with core activities in milk, fresh dairy foods, juice and specialty cheese. National Foods' Pura Milk is the country's number one milk brand. Additionally, National Foods is the largest citrus and fruit processor in Australia, packaging approximately 50 percent of all fruit juice beverages sold nationally. For more information on National Foods, visit http://www.natfoods.com.au .

Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA, a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com. For a complete list of product, visit http://www.lifesdha.com.

Sections of this release contain forward-looking statements. These statements are based upon numerous assumptions which Martek cannot control and involve risks and uncertainties that could cause actual results to differ. These statements should be understood in light of the risk factors set forth in the company's filings with the Securities and Exchange Commission, including, but not limited to, the company's Form 10-K for the fiscal year ended October 31, 2007 and other filed reports on Form 10-K, Form 10-K/A, Form 10-Q and Form 8-K.

Contact:

Cassie France-Kelly

Public Relations

Martek Biosciences

(443) 542-2116

media@martek.com

Kyle Stults

Investor Relations

Martek Biosciences

(410) 740-0081

investors@martek.com


'/>"/>
SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers develop a method to select eggs with the best chance of leading to successful pregnancy
2. Leading researchers honored for progress in cancer prevention, detection and treatment
3. Following School Suicide, National Childrens Charity Issues Tips and Free Resources to Help Prevent 3rd Leading Cause of Death Among Youth
4. Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
5. Leading Arizona Radiological Group Selects MedQuist for Speech Recognition Solution
6. Leading Health Groups Strongly Support the Minnesota Department of Healths Efforts to Enforce Freedom to Breathe Act
7. Home Oxygen Community Applauds Senator Pat Roberts for Leading Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
8. Home Oxygen Community Applauds Senator Blanche Lincoln for Leading Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
9. Leading Natural Cosmetics Company Supports Breast Cancer Survivors
10. Scientists uncover further steps leading to celiac disease
11. IDC X-Series DR system selected for use in leading edge RSA clinical trial application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , ... February 08, 2016 , ... Guruji Mahendra Kumar ... 10th and 11th, 2016 in honor of his birthday on February 10th. During ... Mahendra Trivedi is known by over 250,000 people from over 40 different countries ...
(Date:2/7/2016)... Metamora, Michigan (PRWEB) , ... February 07, 2016 ... ... pelvic organ prolapse with the latest techniques and the most minimally invasive approaches. ... pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to the ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... ... ... With the FCPX LUT: Summer pack from Pixel Film Studios, ... is a Lookup Table that contains a mathematical formula for modifying an image. The ... manipulating each pixel, LUT's can change each color range differently, it gives the user ...
(Date:2/5/2016)... SARASOTA, Florida (PRWEB) , ... February 05, 2016 , ... ... an event he has completed every year since it started in 2003. This year, ... attracting the attention of fellow runners and NBA team the Miami Heat. , This ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 Velano Vascular, a ... for hospitalized patients and their practitioners, announced today that ... funding. Velano will use the proceeds from this financing, ... completed in January 2015, to support the development and ... and pediatric populations. Philadelphia ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016  HemaFlo Therapeutics, Inc. ... (USPTO) has issued US Patent Number 9,119,880 covering the use ... Dale Peterson , PhD, HemaFlo,s founder, said, "We are ... --> Dale Peterson , PhD, HemaFlo,s founder, ... a powerful technology." --> Dale Peterson ...
(Date:2/8/2016)... NORTHBROOK, Ill. , Feb. 8, 2016  Astellas Pharma ... today announced the promotion of James Robinson as ... the company,s operations in North and South America ... president, Astellas Pharma US, representing the commercial organization in ... assumed in 2013. Masao Yoshida , who ...
Breaking Medicine Technology: